Literature DB >> 10440067

The expression of p53, Ki-67 and urokinase plasminogen activator receptor in colorectal adenomas with true invasion and pseudoinvasion.

T P Hansen1, C Fenger, O Kronborg.   

Abstract

The recognition of pseudoinvasion is important in the differential diagnosis of adenocarcinoma in patients with adenomas. This distinction might occasionally be difficult, particularly when the dysplasia is pronounced. The present study was undertaken in order to investigate whether the immunohistochemical expression of p53, Ki-67 and the urokinase plasminogen activator receptor (uPAR) was different in adenomas with true invasion and pseudoinvasion. We studied 26 formalin-fixed, paraffin-embedded tumor samples, consisting of 10 cases of adenomas with pseudoinvasion and 16 cases of adenocarcinomas in adenomas. In this series of selected histologically typical cases a constant moderate or strong reaction for uPAR was present at the invasive front in all of the 16 adenomas with adenocarcinoma, but only focally in one of 10 adenomas with pseudoinvasion. The reactions for p53 and Ki-67 showed only minor differences. In conclusion, the immunohistochemical reaction for uPAR seems to be a useful supplement in cases without typical histology or with severe dysplasia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440067     DOI: 10.1111/j.1699-0463.1999.tb01461.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  2 in total

1.  Diagnosis of T1 colorectal cancer in pedunculated polyps in daily clinical practice: a multicenter study.

Authors:  Yara Backes; Leon Mg Moons; Marco R Novelli; Jeroen D van Bergeijk; John N Groen; Tom Cj Seerden; Matthijs P Schwartz; Wouter H de Vos Tot Nederveen Cappel; Bernhard Wm Spanier; Joost Mj Geesing; Koen Kessels; Marjon Kerkhof; Peter D Siersema; G Johan A Offerhaus; Anya N Milne; Miangela M Lacle
Journal:  Mod Pathol       Date:  2016-10-07       Impact factor: 7.842

2.  Enteritis cystica profunda.

Authors:  C F J Ng; D A Hull; R M Feakins; S Baithun; S Dorudi
Journal:  J R Soc Med       Date:  2004-01       Impact factor: 18.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.